| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Institute of Child Health |
| Information provided by: | Institute of Child Health |
| ClinicalTrials.gov Identifier: | NCT00415935 |
Purpose
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
| Condition | Intervention |
|
Juvenile Idiopathic Arthritis |
Drug: methotrexate |
| MedlinePlus related topics: | Juvenile Rheumatoid Arthritis |
| ChemIDplus related topics: | Methotrexate |
| Study Type: | Observational |
| Study Design: | Longitudinal, Defined Population, Prospective Study |
Eligibility
| Ages Eligible for Study: | up to 16 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| Contact: Lucy Wedderburn, Dr | l.wedderburn@ich.ucl.ac.uk |
| United Kingdom | |||||
| Rheumatology ICH | Recruiting | ||||
| London, United Kingdom, WC1N 1EH | |||||
| Contact: Lucy Wedderburn, Dr l.wedderburn@ich.ucl.ac.uk | |||||
| Institute of Child Health |
| Principal Investigator: | Lucy Wedderburn, Dr | Institute Of Child Health and Great Ormond Street Hospital |
More Information
| Study ID Numbers: | 04RU01 |
| First Received: | December 22, 2006 |
| Last Updated: | December 23, 2006 |
| ClinicalTrials.gov Identifier: | NCT00415935 |
| Health Authority: | United Kingdom: Research Ethics Committee |
|
|
|
|
|
